Icosapent Ethyl Supplementation and Cardiovascular Prevention-Implications of Evolving Data.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.3701
Abstract: This Viewpoint discusses the findings of the Reduction of Cardiovascular Events With Icosapent Ethyl Intervention Trial regarding the use of icosapent ethyl in moderate- to high-risk patients with fasting triglyceride levels greater than 135 mg/dL. read more here.
Keywords: icosapent ethyl; icosapent; cardiovascular prevention; ethyl supplementation ... See more keywords